SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-031101
Filing Date
2022-11-09
Accepted
2022-11-09 16:16:16
Documents
42
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 737820
2 ex10-1.htm EX-10.1 911
3 ex10-2.htm EX-10.2 884
4 ex31-1.htm EX-31.1 17417
5 ex31-2.htm EX-31.2 17946
6 ex32-1.htm EX-32.1 7284
7 ex32-2.htm EX-32.2 7056
8 ex10-1_001.jpg GRAPHIC 121279
9 ex10-2_001.jpg GRAPHIC 137162
  Complete submission text file 0001493152-22-031101.txt   3758125

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE immx-20220930.xsd EX-101.SCH 18957
11 XBRL CALCULATION FILE immx-20220930_cal.xml EX-101.CAL 32839
12 XBRL DEFINITION FILE immx-20220930_def.xml EX-101.DEF 95072
13 XBRL LABEL FILE immx-20220930_lab.xml EX-101.LAB 245860
14 XBRL PRESENTATION FILE immx-20220930_pre.xml EX-101.PRE 178990
36 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 442316
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

IRS No.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41159 | Film No.: 221372827
SIC: 2834 Pharmaceutical Preparations